https://www.selleckchem.com/pr....oducts/reparixin-rep
ptide-magnetic nanoparticles was firstly applied in NSCLC patients. Compared with the antibody-based the technique, the higher CTC detection rates (71.4%) in NSCLC patient blood samples were demonstrated for the patients in different stages, I-IV, especially in early stages. This indicates the feasibility of the clinical utility of this new technique in early stage screening, prognosis and therapy evaluation of NSCLC. Highly efficient CTC isolation technique based on peptide-magnetic nanoparticles was firstly applied in NSC
Like
Comment
Share
